Xcellerate® is an advanced dual-layer amniotic membrane allograft developed to support dermal regeneration in challenging wound environments. As part of New Horizon Medical Solutions’ biologics portfolio—and originally developed through the innovation of Precise Bioscience—Xcellerate® provides a robust, biologically active scaffold ideal for wounds requiring enhanced moisture retention, structural integrity, and sustained healing support.

The product’s thicker, multi-layered construction ensures superior handling, prolonged wound coverage, and mechanical resilience, making it a powerful tool for both outpatient and surgical wound care protocols.